I samtlige kliniske undersøgelser blev personer, som havde modtaget immunoglobulin eller produkter afledt af blod i 6 måneder forud for den første vaccinedosis, udelukket.
In all clinical trials, individuals who had received immunoglobulin or blood-derived products during the 6 months prior to the first vaccine dose were excluded.